Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vivus
Vivus
Vivus, Arena, Or Orexigen - Which Will Win The Anti-Obesity Market Share Race?
Seeking Alpha
Tue, 03/24/15 - 08:30 am
Vivus
Orexigen
Arena Pharmaceuticals
Contrave
Belviq
Qsymia
obesity
Vivus: Teva Wants To Make Generic Qsymia - Can This Be Good?
Seeking Alpha
Wed, 03/11/15 - 03:17 pm
Vivus
Teva Pharmaceutical
generics
Qsymia
Vivus' Suit Against Actavis Gets Some Dates - Is Trouble Ahead?
Seeking Alpha
Sat, 03/7/15 - 11:18 am
Vivus
Actavis
Qsymia
Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus
TheStreet.com
Sat, 02/21/15 - 09:44 am
obesity
Orexigen
Arena
Vivus
Belviq
Contrave
Qsymia
Vivus' Qsymia Experiencing Both Prescription Growth And Market Share Erosion
Seeking Alpha
Wed, 02/18/15 - 10:52 am
Vivus
Qsymia
obesity
Orexigen
Arena Pharmaceuticals
Contrave
Belviq
With Flat Qsymia Sales, Vivus May Shift Focus To Stendra/Spedra
Seeking Alpha
Fri, 02/6/15 - 08:08 am
Vivus
Qsymia
Stendra
Spedra
erectile dysfunction
5 Obesity Stocks Investors Are Watching
Yahoo/Benzinga
Thu, 01/15/15 - 08:53 am
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
APD334
Vivus
Qsymia
EnteroMedics
devices
Maestro System
Novo Nordisk
Saxenda
Is Vivus Headed Towards An Unfortunate Ending?
Seeking Alpha
Mon, 12/29/14 - 11:10 am
Vivus
Qsymia
Best and worst 2014 biotech performers on Wall Street
Fierce Biotech
Tue, 12/23/14 - 10:24 am
Avanir Pharmaceuticals
Agios Pharmaceuticals
TG Therapeutics
Bluebird Bio
Vivus
Agerion
Theravance
Arena And Vivus Investors Need To Grasp Implications Of Orexigen
Seeking Alpha
Fri, 12/19/14 - 04:08 pm
Arena Pharmaceuticals
Vivus
Contrave
Belviq
Qsymia
Vivus Tries To Lead Obesity Space With Insurance Coverage
Seeking Alpha
Tue, 12/16/14 - 08:18 am
Vivus
obesity
insurance
Qsymia
VIVUS Announces Favorable Formulary Positioning for Qsymia
Yahoo
Mon, 12/15/14 - 08:01 am
Vivus
Qsymia
formulary
Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals
Adam on Biotech Stocks
Fri, 12/12/14 - 12:33 pm
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
Vivus
Qsymia
The Odds Of Success For The New Obesity Drugs
CP Wire
Mon, 12/8/14 - 11:45 am
obesity
Belviq
Contrave
Qsymia
Arena Pharmaceuticals
Vivus
Orexigen
Will Diabetes Drugs Enter The Anti-Obesity Space?
Seeking Alpha
Mon, 12/8/14 - 08:30 am
diabetes
obesity
Arena Pharmaceuticals
Novo Nordisk
AstraZeneca
Orexigen
Vivus
Farxiga
Victoza
Invokana
Vivus awarded two patents for Qsymia
Seeking Alpha
Wed, 11/26/14 - 12:05 pm
Vivus
Qsymia
patents
Why VIVUS (VVUS) Might Be a Diamond in the Rough
Yahoo/Zacks.com
Wed, 11/19/14 - 08:24 am
Vivus
Arena And Vivus Investors Need To Watch Orexigen
Seeking Alpha
Tue, 11/11/14 - 10:38 am
Arena Pharmaceuticals
Orexigen
Vivus
obesity
Vivus posts 3Q loss, results beat Street expectations
Yahoo/AP
Wed, 11/5/14 - 07:39 pm
Vivus
earnings
3 Pharma Companies Fighting Obesity
Yahoo/Benzinga
Thu, 10/30/14 - 05:33 pm
obesity
Orexigen
Arena
Vivus
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »